Steven Frank - 22 Feb 2022 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
Director
Signature
/s/ Steven Frank, by Donald P. Lehr, as attorney-in-fact
Issuer symbol
PGEN
Transactions as of
22 Feb 2022
Net transactions value
+$49,999
Form type
4
Filing time
24 Feb 2022, 16:45:41 UTC
Next filing
29 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Award $49,999 +24,630 +7.3% $2.03 361,835 22 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Award $0 +61,576 $0.000000 61,576 22 Feb 2022 Common Stock 61,576 Direct F2, F3
transaction PGEN Option to Purchase Common Stock (Right to Buy) Award $0 +83,189 $0.000000 83,189 22 Feb 2022 Common Stock 83,189 $2.03 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued to the reporting person in lieu of an annual retainer of $50,000.
F2 Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.
F3 The RSUs vest in full on February 22, 2023.